There is good evidence that HCC surveillance with six monthly ultrasounds, with or without alpha-fetoprotein measurement, increases the probability of earlier-stage diagnosis of HCC, thereby improving survival [8]. The gene discussed is AFP; the disease is hepatocellular carcinoma.